Against: And just what is the emperor of stroke wearing?
- 1 September 2000
- journal article
- Published by BMJ in Western Journal of Medicine
- Vol. 173 (3) , 149-150
- https://doi.org/10.1136/ewjm.173.3.149
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Use of Tissue-Type Plasminogen Activator for Acute Ischemic StrokeJAMA, 2000
- Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom OnsetJAMA, 1999
- Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation modelBMJ, 1999
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)Published by Elsevier ,1998
- Cranial Computed Tomography Interpretation in Acute StrokeJAMA, 1998
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Conditions That Mimic Stroke in the Emergency DepartmentArchives of Neurology, 1995
- Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 1995